This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
AOP: 281
Title
Acetylcholinesterase Inhibition Leading to Neurodegeneration
Short name
Graphical Representation
Point of Contact
Contributors
- Kendra Conrow
- Karen Watanabe
- Natalia Reyero
- Priscilla Pacheco
- Dennis Sinitsyn
- Allie Always
Coaches
OECD Information Table
| OECD Project # | OECD Status | Reviewer's Reports | Journal-format Article | OECD iLibrary Published Version |
|---|---|---|---|---|
This AOP was last modified on September 25, 2023 16:26
Revision dates for related pages
| Page | Revision Date/Time |
|---|---|
| Acetylcholinesterase (AchE) Inhibition | April 29, 2020 17:21 |
| Acetylcholine accumulation in synapses | June 26, 2020 13:06 |
| Activation, Muscarinic Acetylcholine Receptors | April 17, 2020 13:09 |
| Overactivation, NMDARs | January 04, 2023 18:39 |
| Increased, Intracellular Calcium overload | June 26, 2020 04:45 |
| Cell injury/death | July 15, 2022 09:46 |
| Occurrence, Focal Seizure | May 20, 2020 01:40 |
| N/A, Neurodegeneration | February 23, 2021 05:07 |
| Status epilepticus | May 21, 2020 18:26 |
| Increased, glutamate | October 11, 2021 14:58 |
| AchE Inhibition leads to ACh Synaptic Accumulation | July 11, 2023 20:54 |
| ACh Synaptic Accumulation leads to Activation, Muscarinic Acetylcholine Receptors | June 19, 2023 16:00 |
| Activation, Muscarinic Acetylcholine Receptors leads to Occurrence, Focal Seizure | June 19, 2023 17:13 |
| Occurrence, Focal Seizure leads to Increased, glutamate | June 19, 2023 17:28 |
| Increased, glutamate leads to Overactivation, NMDARs | June 19, 2023 17:46 |
| Overactivation, NMDARs leads to Status epilepticus | July 24, 2023 22:48 |
| Status epilepticus leads to Increased, glutamate | June 21, 2023 20:11 |
| Overactivation, NMDARs leads to Increased, Intracellular Calcium overload | July 11, 2023 23:43 |
| Status epilepticus leads to Increased, Intracellular Calcium overload | July 24, 2023 22:52 |
| Increased, Intracellular Calcium overload leads to Cell injury/death | June 21, 2023 20:36 |
| Cell injury/death leads to N/A, Neurodegeneration | June 15, 2023 21:15 |
Abstract
The enzyme acetylcholinesterase (AChE) hydrolyzes acetylcholine (ACh) in order to eliminate it from the body. When AChE is inhibited ACh levels increase. An excess of ACh at cholinergic synapses overstimulates both muscarinic- and nicotinic- receptors (1,2). These receptors are found in most organs in the body, thus the effects of AChE inhibition can result in multiple adverse outcomes affecting a wide variety of functions (1). This AOP focuses upon an acute outcome of neurodegeneration due to AChE inhibition specifically through calcium dysregulation as that has been identified as central to the development of the most severe phenotype caused by acute organophosphate poisoning (3).
1. United States., Environmental Protection Agency., Office of Pesticide Programs. (2000). The Use of Data on Cholinesterase Inhibition for Risk Assessments of Organophosphorous and Carbamate Pesticides. https://www.epa.gov/sites/production/files/2015-07/documents/cholin.pdf accessed Nov. 2018.
2. Quick, M. W., & Lester, R. A. J. (2002). Journal of Neurobiology, 53(4), 457-478. doi:10.1002/neu.10109.
3. Faria et al. (2015). Scientific Reports, 5. doi:10.1038/srep15591.
AOP Development Strategy
Context
Epidemiological studies concerning OP pesticides estimated approximately 3 million cases of acute severe poisoning, as well as 300,000 deaths annually. Most of those deaths occur in developing countries of the Asia-Pacific region (Bertolote et al., 2006). These OP compounds can also be used as chemical warfare nerve agents. The improper use of OP chemicals has tragic consequences such as neurodegeneration, brain damage, and death underscoring the need for safety measures that protect both human health and the environment.
Bertolote, J. M., Fleischmann, A., Eddleston, M. & Gunnell, D. 2006. Deaths from pesticide poisoning: A global response. British Journal of Psychiatry, 189, 201-203. DOI: 10.1192/bjp.bp.105.020834.
Strategy
Construction of AOP 281 started from the bottom up, and involved searching the literature and consultation with experts in neuroscience. Extensive literature searches were conducted in Scopus and Pubmed using keywords such as, “acetylcholinesterase inhibition”, “muscarinic acetylcholine receptor”, “calcium dysregulation”, “organophosphate”, “glutamate”, and “cell death” with an initial focus on zebrafish data. Over 300 papers were reviewed and categorized by whether they contained data to support one or more parts of the AOP. An Excel spreadsheet was used to record reviewed papers and which part(s) of the AOP they supported.
AOP 281 was developed primarily by the authors and experts in this publication, except when existing KEs or KERs are used in the AOP. These existing KEs and KERs have additional authors who are not explicitly cited herein. Three KEs of the 10 in AOP 281 (including the MIE and AO as key events), and eight KERs of eleven were developed specifically for this AOP. The remaining KEs and KERs were modified accordingly to include additional data specific for AOP 281.
Summary of the AOP
Events:
Molecular Initiating Events (MIE)
Key Events (KE)
Adverse Outcomes (AO)
| Type | Event ID | Title | Short name |
|---|
| MIE | 12 | Acetylcholinesterase (AchE) Inhibition | AchE Inhibition |
| KE | 10 | Acetylcholine accumulation in synapses | ACh Synaptic Accumulation |
| KE | 1602 | Activation, Muscarinic Acetylcholine Receptors | Activation, Muscarinic Acetylcholine Receptors |
| KE | 1623 | Occurrence, Focal Seizure | Occurrence, Focal Seizure |
| KE | 1350 | Increased, glutamate | Increased, glutamate |
| KE | 388 | Overactivation, NMDARs | Overactivation, NMDARs |
| KE | 1788 | Status epilepticus | Status epilepticus |
| KE | 389 | Increased, Intracellular Calcium overload | Increased, Intracellular Calcium overload |
| KE | 55 | Cell injury/death | Cell injury/death |
| AO | 352 | N/A, Neurodegeneration | N/A, Neurodegeneration |
Relationships Between Two Key Events (Including MIEs and AOs)
| Title | Adjacency | Evidence | Quantitative Understanding |
|---|
| AchE Inhibition leads to ACh Synaptic Accumulation | adjacent | High | Moderate |
| ACh Synaptic Accumulation leads to Activation, Muscarinic Acetylcholine Receptors | adjacent | Moderate | High |
| Activation, Muscarinic Acetylcholine Receptors leads to Occurrence, Focal Seizure | adjacent | Moderate | Low |
| Occurrence, Focal Seizure leads to Increased, glutamate | adjacent | Moderate | Low |
| Increased, glutamate leads to Overactivation, NMDARs | adjacent | Moderate | High |
| Overactivation, NMDARs leads to Status epilepticus | adjacent | Moderate | Low |
| Status epilepticus leads to Increased, glutamate | adjacent | Moderate | Low |
| Overactivation, NMDARs leads to Increased, Intracellular Calcium overload | adjacent | High | Moderate |
| Status epilepticus leads to Increased, Intracellular Calcium overload | adjacent | High | Low |
| Increased, Intracellular Calcium overload leads to Cell injury/death | adjacent | High | Low |
| Cell injury/death leads to N/A, Neurodegeneration | adjacent | High | Low |
Network View
Prototypical Stressors
Life Stage Applicability
Taxonomic Applicability
Sex Applicability
Overall Assessment of the AOP
Domain of Applicability
Essentiality of the Key Events
Evidence Assessment
Known Modulating Factors
| Modulating Factor (MF) | Influence or Outcome | KER(s) involved |
|---|---|---|